Curexo (060280.KQ) Earnings Analysis
Curexo (060280.KQ) has no confirmed upcoming earnings date. Trailing P/E 163.34.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 060280.KQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 060280.KQ. This page updates as the calendar is published.
060280.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-05 | 42.48 KRW | n/a | n/a | n/a |
| 2024-12-31 | -130.95242 KRW | n/a | n/a | n/a |
| 2024-09-30 | -38 KRW | n/a | n/a | n/a |
060280.KQ valuation and analyst view
| Trailing P/E | 163.34 |
|---|---|
| Trailing EPS | 51.934 KRW |
| Price / book | 3.53 |
| Dividend yield | 0.00% |
| Market cap | 330.08B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Curexo (060280.KQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 060280.KQ. This page updates as the calendar is published.
Did 060280.KQ beat earnings last quarter?
Consensus estimate data was not available for 060280.KQ's 2026-02-05 report.
What is 060280.KQ's current P/E ratio and EPS?
060280.KQ trades at a trailing P/E of 163.34 on trailing EPS of 51.93410534522512 KRW.
What do analysts rate 060280.KQ?
060280.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.